澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MAYNE PHARMA GROUP LTD

2.550

-0.060-2.30%

成交量：7.58萬

成交額：19.61萬

市值：2.07億

市盈率：-2.15

高：2.640

開：2.610

低：2.535

收：2.610

52周最高：7.310

52周最低：2.535

股本：8,124.58萬

流通股本：6,699.72萬

量比：0.59

換手率：0.11%

股息：- -

股息率：- -

每股收益(TTM):-1.188

每股收益(LYR):-1.186

淨資產收益率：-21.85%

總資產收益率：-1.28%

市淨率：0.56

市盈率(LYR):-2.15

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股-0.64%

資金流向

資金流入：

資金流出：

新聞資訊

Mayne製藥集團——將繼續推進產品組合規模化戰略，可能包含股票回購計劃

MAYNE PHARMA GROUP LTD上訴理由曝光，擬挑戰法院對該公司2025財年息税折舊攤銷前利潤等事項的裁決

Mayne Pharma收到Cosette及其Bidco向新南威爾士州最高法院上訴庭提交的上訴通知

MAYNE PHARMA GROUP LTD - 擴建生產設施正式啓用儀式在南澳大利亞薩爾斯堡舉行

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MYX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.55,"timestamp":1771893700899,"preClose":2.61,"halted":0,"volume":75752,"delay":0,"changeRate":-0.022988505747126457,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.187574,"marketStatus":"交易中","change":-0.06,"latestTime":"02-24 11:42:08 AEDT","open":2.61,"high":2.64,"low":2.535,"amount":196073,"amplitude":0.04023,"askPrice":2.56,"askSize":2039,"bidPrice":2.55,"bidSize":706,"shortable":3,"etf":0,"ttmEps":-1.187574,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1771909200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.61,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":0.592676,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.28%","roe":"-21.85%","lyrEps":-1.185711,"volumeRatio":0.592676,"shares":81245827,"dividePrice":0,"high":2.64,"amplitude":0.04023,"preClose":2.61,"low":2.535,"week52Low":2.535,"pbRate":"0.56","psRate":"0.51","week52High":7.31,"institutionHeld":0,"latestPrice":2.55,"committee":-0.48561,"eps":-1.187574,"divideRate":0,"volume":75752,"delay":0,"ttmEps":-1.187574,"open":2.61,"prevYearClose":3.11,"prevWeekClose":2.65,"prevMonthClose":2.8,"prevQuarterClose":3.11,"fiveDayClose":2.65,"twentyDayClose":2.83,"sixtyDayClose":3.67,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174229185","title":"Mayne製藥集團——將繼續推進產品組合規模化戰略，可能包含股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1174229185","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174229185?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 06:38","pubTimestamp":1771799894,"startTime":"0","endTime":"0","summary":"Mayne制药集团宣布将持续推进其产品组合的规模化战略，并透露未来可能采取包括股票回购在内的多元化举措。这一战略方向旨在优化公司资本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1112976135","title":"MAYNE PHARMA GROUP LTD上訴理由曝光，擬挑戰法院對該公司2025財年息税折舊攤銷前利潤等事項的裁決","url":"https://stock-news.laohu8.com/highlight/detail?id=1112976135","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112976135?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 12:57","pubTimestamp":1768453037,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD已提交上诉通知书，其中列明的上诉理由旨在对法院就该公司2025财年息税折旧摊销前利润及其他相关财务指标所作出的认定提出异议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1175178833","title":"Mayne Pharma收到Cosette及其Bidco向新南威爾士州最高法院上訴庭提交的上訴通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1175178833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175178833?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 12:56","pubTimestamp":1768453014,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd（ASX: MYX）近日宣布，已收到Cosette Pharmaceuticals及其关联收购实体（Bidco）向澳大利亚新南威尔士州最高法院上诉庭提交的上诉通知书。该上诉针对此前法院作出的相关裁决提出异议，标志着双方围绕商业纠纷的法律对抗进入新一轮司法程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1124731935","title":"MAYNE PHARMA GROUP LTD - 擴建生產設施正式啓用儀式在南澳大利亞薩爾斯堡舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=1124731935","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124731935?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 10:43","pubTimestamp":1765852990,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.006385}]}}